Manchar Diagnostics Centre Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 21-12-2024
- Paid Up Capital ₹ 4.05 M
as on 21-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.60 M
as on 21-12-2024
- Revenue -48.19%
(FY 2019)
- Profit -1726.34%
(FY 2019)
- Ebitda -11.97%
(FY 2019)
- Net Worth -9.48%
(FY 2019)
- Total Assets -25.99%
(FY 2019)
About Manchar Diagnostics Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 4.05 M.
The company currently has active open charges totaling ₹1.60 M.
Sunil Khinvansara, Sachin Gade, Kiran Lokhande, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74999PN2016PTC164868
- Company No.
164868
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Manchar Diagnostics Centre?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Gade  | Director | 07-Jun-2016 | Current |
| Narendra Lohokare | Director | 07-Jun-2016 | Current |
| Sunil Khinvansara | Director | 07-Jun-2016 | Current |
| Kiran Lokhande | Director | 07-Jun-2016 | Current |
| Harshad Shete | Director | 07-Jun-2016 | Current |
| Atul Shinde | Director | 07-Jun-2016 | Current |
Financial Performance of Manchar Diagnostics Centre.
Manchar Diagnostics Centre Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 48.19% decrease. The company also saw a substantial fall in profitability, with a 1726.34% decrease in profit. The company's net worth dipped by a decrease of 9.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manchar Diagnostics Centre?
In 2019, Manchar Diagnostics Centre had a promoter holding of 32.10% and a public holding of 67.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Jun 2017 | ₹1.60 M | Open |
How Many Employees Work at Manchar Diagnostics Centre?
Unlock and access historical data on people associated with Manchar Diagnostics Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manchar Diagnostics Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manchar Diagnostics Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
